Oncology
Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million
Published in Surgery Litigation and Law Weekly, December 28th, 2007
Boston Scientific Corporation (NYSE:BSX) and Avista Capital Partners, a leading private equity firm, today jointly announced the signing of a definitive agreement under which Avista will acquire from Boston Scientific its Fluid Management and Venous Access businesses for $425 million in cash. The transaction is expected to close in the first quarter of 2008, subject to regulatory approvals and customary conditions. Boston Scientific previously announced its intent to sell these businesses as part of its plan to divest non-strategic assets.
Avista said that upon close of the transaction, the combined Fluid Management/Venous Access business will operate as an independent...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Consumers Union
Survey Finds U.S. Healthcare Facilities Not Doing Enough to Curb MRSA - Flaster/Greenberg P.C.
N.J. Codey Ruling, 'A Dramatic Threat' to N.J. Ambulatory Surgical Centers - Joel Schlessinger M.D.
Will Lipodissolve Continue to Remain Popular? - Keratitis
20 Additional Lawsuits Filed Against Advanced Medical Optics Over Recalled Contact Lens Solution - Patents
Bard Announces Patent Infringement Verdict against W. L. Gore & Associates - The Doctors Company
System Errors Contribute to 30 Percent of Settled Malpractice Claims, According to New Claims Analysis by the Doctors Company - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
